Select Language

Gastrin-17

Gastrin-17 Overview

English Name	Gastrin 17	Approved Drugs	0
Drugs in Clinical Trials	1	Target Synonym	Gastrin component II，Gastrin component III，GAS，G52，G34，G14，G17，G6，GAST，Gastrin component I，Gastrin-34，Gastrin-17，Gastrin，Preprogastrin
Highest Development Stage	Phase 2 Clinical

English Name	Gastrin 17
Target Synonym	Gastrin component II，Gastrin component III，GAS，G52，G34，G14，G17，G6，GAST，Gastrin component I，Gastrin-34，Gastrin-17，Gastrin，Preprogastrin
Approved Drugs	0
Drugs in Clinical Trials	1
Highest Development Stage	Phase 2 Clinical

Gastrin-17 Product List

Product Category
Protein (1)
Product Status
Launched (1)
Species
Human (1)
Tag
Fc Tag & Avi Tag (1)
Conjugate
Biotin-labeled (1)

Cat. No.	Species	Host	Product Description	Structure	Purity	Feature
GA7-H82F4	Human	HEK293	Biotinylated Human Gastrin-17 Protein, Fc,Avitag™ (MALS verified)

Total: 1

Gastrin-17 Background

Gastrin is a peptide hormone that stimulates secretion of gastric acid (HCl) by the parietal cells of the stomach and aids in gastric motility. It is released by G cells in the pyloric antrum of the stomach, duodenum, and the pancreas. Gastrin binds to cholecystokinin B receptors to stimulate the release of histamines in enterochromaffin-like cells, and it induces the insertion of K+/H+ ATPase pumps into the apical membrane of parietal cells (which in turn increases H+ release into the stomach cavity). Its release is stimulated by peptides in the lumen of the stomach.

Gastrin-17 Synonyms

gastrin-17,gastrin 17,gastrin

Clinical Drug Information

English Name	Research Code	Highest Development Stage	Company	Indication	Clinical Trial
Polyclonal antibody stimulator (Cancer Advances)	G-17DT	Phase 2 Clinical	Aphton Corp	Colorectal Neoplasms; Diabetes Mellitus, Type 1; Esophageal Neoplasms; Jaundice; Pancreatic Neoplasms; Stomach Neoplasms	Details